Shana Alex CharlesCalifornia State University, Fullerton | CSUF
Shana Alex Charles
About
55
Publications
5,007
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
22
Citations
Publications
Publications (55)
The version of California Assembly Bill (AB) 2516 analyzed by CHBRP would require DMHC-regulated plans and CDI-regulated policies to provide coverage for the human papillomavirus (HPV) vaccine for enrollees for whom it is approved by the FDA. Plans and policies would be prohibited from charging cost sharing for the HPV vaccine. The bill would also...
The version of California Assembly Bill 2024 analyzed by CHBRP would require coverage for breast imaging and would prohibit some cost sharing. In 2023, of the 22.8 million Californians enrolled in state-regulated health insurance, 100% would have insurance subject to AB 2024.
The version of California Senate Bill 974 analyzed by CHBRP would require coverage for breast imaging and would prohibit some cost sharing. In 2023, of the 22.8 million Californians enrolled in state-regulated health insurance, 100% would have insurance subject to SB 974.
The version of California Assembly Bill (AB) 1520 analyzed by CHBRP would prohibit cost sharing on coverage for prostate cancer screening for enrollees with a prostate who are either aged 55 years or older, or aged 40 years or older and considered high risk. Under AB 1520, the high-risk population includes but is not limited to Black individuals wi...
The version of California Senate Bill (SB) 245 analyzed by CHBRP would prohibit cost sharing for all abortion services, including follow-up services such as management of side effects and counseling. It also prohibits health plans and policies from imposing any restrictions or delays on abortion services, including prior authorization, and prohibit...
This policy brief describes voter registration and participation among California adults, using data from the 2017-2018 California Health Interview Survey (CHIS). Better health status, lower levels of psychological distress, and better access to health care were related to higher levels of voter participation. Higher levels of voter registration an...
For commercial/CalPERS enrollees in plans and policies regulated by Department of Managed Health Care (DMHC) or California Department of Insurance (CDI), the version of California Assembly Bill 2204 analyzed by CHBRP would require coverage of sexually transmitted disease (STD) services provided by out-of-network clinics that receive state/county fu...
For commercial/CalPERS enrollees with coverage for outpatient prescription medications, Senate Bill (SB) 854 would require on-formulary, low-tier coverage of Food and Drug Administration (FDA) approved substance use disorder (SUD) medications and would prohibit some utilization management. It would also prohibit requiring prior authorization for co...
Non-partisan limited/fiscal impact analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for California Senate Bill 583
Clinical Trials
Non-partisan limited/fiscal impact analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for California Senate Bill 163 Autism
As Medi-Cal enrollment expanded during the early years of ACA expansion (2014 and 2015), county health department spending in California also swelled. For most counties and regions in the state, the two measures tracked closely. However, exceptions in Northern California (with high enrollment and low spending growth) and Central California (low enr...
Background and purpose:
Following the Affordable Care Act (ACA) health insurance expansions, this study asks: did racial/ethnic group disparities in access to care remain? And specifically, did Latinos experience worse access to care after the ACA expansions compared to other racial/ethnic groups?
Methods:
Dataset: 2015 California Health Intervi...
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for Comprehensive Medication Management
Non-partisan literature review of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for Medi-Cal: Telehealth and Substance Use Disorder Services
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for Advanced Practice Pharmacistberkele
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for Assembly Bill 2193
Maternal Mental Health
Non-partisan literature review of the medical effectiveness of dense breast notification legislation
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for Dentistry: General Anesthesia
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of California Assembly Bill 2643 Dentistry: General Anesthesia.
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for Medication-Assisted Treatment
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for Prescription Drugs
Addressing racial/ethnic group disparities in health insurance benefits through legislative mandates requires attention to the different proportions of racial/ethnic groups among insurance markets. This necessary baseline data, however, has proven difficult to measure. We applied racial/ethnic data from the 2009 California Health Interview Survey t...
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of proposed health insurance coverage for fertility preservation in California.
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for Drug Utilization Management Exceptions
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for Pervasive Developmental Disorder or Autism
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of California Senate Bill 399 Pervasive Developmental Disorder or Autism
The version of California Assembly Bill (AB) 1107 analyzed by CHBRP would require a health plan or insurer that develops and implements a clinical pathway for cancer treatment, as defined, to comply with certain requirements. In addition, the bill would prohibit a plan/insurer from developing and implementing an oncology clinical pathway (OCP) that...
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for Pervasive Developmental Disorder or Autism
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for Fertility Preservation
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for Fertility Preservation
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for Fertility Preservation
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for HIV Specialists
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for Continuous Glucose Monitors
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for HIV Specialists
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for Hearing Aids: Minors
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for Medi-Cal: Asthma Preventive Services
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for HIV Associated Lipodystrophy
On September 23, 2016, California became the 6th state to pass legislation requiring health plans and insurers to cover a 12-month supply of FDA-approved self-administered hormonal contraceptives such as contraceptive pills, patches, and vaginal rings. This legislation is estimated to result in 47% of current contraceptive pill, patch, and ring use...
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for Health Care Coverage: Mammography.
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for Hearing Aids: Minors
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for HIV Specialists.
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for Childhood Lead Poisoning: Prevention
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for Telehealth: Access.
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for Contraceptives: Annual Supply.
Background:
Care delivery redesign in the form of patient-centered medical home (PCMH) is considered as a potential solution to improve patient outcomes and reduce costs, particularly for patients with chronic conditions. But studies of prevalence or impact at the population level are rare.
Objectives:
We aimed to assess whether desired outcomes...
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for abuse-deterrent opioid analgesics
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for outpatient prescriptions drugs.
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for limitations on cost-sharing: family coverage
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for limitations on cost-sharing: family coverage
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for dental hygiene.
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for step therapy coverage http://chbrp.org/
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for telephonic and electronic patient management.
Non-partisan analysis of the medical effectiveness, cost and utilization, and public health impacts of insurance coverage for acquired brain injury
